Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan
Clinical trial NCT02939287 · COMPLETED
Trial details
- NCT number
- NCT02939287
- Sponsor
- Rush University Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-23
- Primary completion
- 2021-12-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.